Analyst Consensus ?
ConsensusHold52 ratings
Bullish2140.4%
Neutral2650.0%
Bearish59.6%
FN2 Earnings Intelligence
Regions Financial Corporation complete analyst coverage
Regions Financial Corporation (RF) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$30.85Current
$18Low
$28.05Average
$35High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Jul 21, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 21, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Jul 20, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 20, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 7, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Jul 6, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 6, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Jul 6, 2026 |
| Baird | Underperform | Neutral | Downgrade | Jul 6, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 29, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 20, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Mar 30, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jan 5, 2026 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Oct 14, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 22, 2025 |
| Compass Point | Buy | Buy | Maintain | Dec 10, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Oct 24, 2024 |
| Argus Research | Buy | Hold | Upgrade | Oct 24, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Oct 21, 2024 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 22, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 3, 2024 |
| Odeon Capital | Hold | Buy | Downgrade | Nov 13, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 1, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Nov 21, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 25, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 20, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jan 21, 2020 |
| Janney Capital | Buy | Neutral | Upgrade | Jan 21, 2020 |
| BMO Capital | Market Perform | Outperform | Downgrade | Nov 12, 2019 |
| Citi | Sell | Neutral | Downgrade | Oct 8, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jul 11, 2019 |
| Sandler O'Neill | Buy | Hold | Upgrade | Mar 25, 2019 |
| B. Riley FBR | Neutral | Neutral | Maintain | May 5, 2018 |
| B. Riley Securities | Neutral | Neutral | Maintain | Apr 24, 2018 |
| FBR Capital | Neutral | Buy | Downgrade | Oct 10, 2017 |
| Susquehanna | Neutral | Positive | Downgrade | Dec 1, 2016 |
| PiperJaffray | Neutral | Overweight | Downgrade | Nov 16, 2016 |
| Bernstein | Market Perform | Outperform | Downgrade | Aug 16, 2016 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Jun 6, 2016 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 1, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | Oct 8, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Oct 8, 2015 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 28, 2015 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jan 21, 2015 |
| Wunderlich | Hold | Buy | Downgrade | Jan 21, 2015 |
| Miller Tabak | Buy | Hold | Upgrade | Aug 8, 2014 |
| ISI Group | Buy | Buy | Maintain | Oct 7, 2013 |
| Sandler O'Neil | Buy | Hold | Upgrade | Mar 6, 2013 |
| Rafferty Capital | Buy | Buy | Maintain | Feb 28, 2013 |
| Drexel Hamilton | Hold | Hold | Maintain | Oct 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $30.85. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Cantor Fitzgerald | Dave Rochester | $35 | $31.11 | +13.5% | Jul 21, 2026 |
| Truist Financial | Analyst unavailable | $34 | $31.11 | +10.2% | Jul 21, 2026 |
| D.A. Davidson | Analyst unavailable | $34 | $31.3 | +10.2% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $34 | $31.65 | +10.2% | Jul 20, 2026 |
| Jefferies | David Chiaverini | $32 | $31.65 | +3.7% | Jul 17, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $34 | $30.92 | +10.2% | Jul 15, 2026 |
| Evercore ISI | Analyst unavailable | $31 | $30.36 | +0.5% | Jul 6, 2026 |
| D.A. Davidson | Analyst unavailable | $33 | $30.28 | +7.0% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $28 | $30.28 | -9.2% | Jul 6, 2026 |
| Morgan Stanley | Analyst unavailable | $35 | $30.16 | +13.5% | Jun 29, 2026 |
| Truist Financial | Analyst unavailable | $30 | $28.41 | -2.8% | Apr 21, 2026 |
| RBC Capital | Analyst unavailable | $31 | $28.38 | +0.5% | Apr 20, 2026 |
| D.A. Davidson | Analyst unavailable | $32 | $28.13 | +3.7% | Apr 20, 2026 |
| UBS | Analyst unavailable | $30 | $30.48 | -2.8% | Feb 4, 2026 |
| Piper Sandler | Analyst unavailable | $31 | $27.77 | +0.5% | Jan 20, 2026 |
| Morgan Stanley | Analyst unavailable | $31 | $27.77 | +0.5% | Jan 19, 2026 |
| Wells Fargo | Analyst unavailable | $30 | $28.52 | -2.8% | Jan 16, 2026 |
| Goldman Sachs | Analyst unavailable | $32 | $28.18 | +3.7% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $30 | $27.56 | -2.8% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $29 | $27.78 | -6.0% | Dec 22, 2025 |
| Stephens | Analyst unavailable | $27 | $24.56 | -12.5% | Oct 14, 2025 |
| Evercore ISI | John Pancari | $29 | $26.5 | -6.0% | Sep 30, 2025 |
| Morgan Stanley | Analyst unavailable | $32 | $26.63 | +3.7% | Sep 29, 2025 |
| Cantor Fitzgerald | Dave Rochester | $30 | $26.82 | -2.8% | Sep 9, 2025 |
| Barclays | Jason Goldberg | $27 | $26.24 | -12.5% | Jul 21, 2025 |
| Stephens | Terry McEvoy | $26 | $24.08 | -15.7% | Oct 29, 2024 |
| Argus Research | Kevin Heal | $26 | $23.78 | -15.7% | Oct 24, 2024 |
| Deutsche Bank | Matt O'Connor | $26 | $23.64 | -15.7% | Oct 24, 2024 |
| Truist Financial | Brandon King | $26 | $23.82 | -15.7% | Oct 21, 2024 |
| D.A. Davidson | Peter Winter | $29 | $23.82 | -6.0% | Oct 21, 2024 |
| Evercore ISI | John Pancari | $26 | $22.54 | -15.7% | Oct 2, 2024 |
| Wedbush | David Chiaverini | $28 | $22.91 | -9.2% | Sep 24, 2024 |
| Citigroup | Keith Horowitz | $26 | $22.72 | -15.7% | Sep 19, 2024 |
| Piper Sandler | Scott Siefers | $23 | $23.07 | -25.4% | Sep 3, 2024 |
| Morgan Stanley | Betsy Graseck | $28 | $22.43 | -9.2% | Jul 30, 2024 |
| D.A. Davidson | Peter Winter | $26 | $22.39 | -15.7% | Jul 22, 2024 |
| Truist Financial | Brandon King | $23 | $22.39 | -25.4% | Jul 22, 2024 |
| Robert W. Baird | David George | $21 | $22.09 | -31.9% | Jul 22, 2024 |
| RBC Capital | Gerard Cassidy | $23 | $22.09 | -25.4% | Jul 22, 2024 |
| Wells Fargo | Mike Mayo | $22 | $22.09 | -28.7% | Jul 21, 2024 |
| Jefferies | Ken Usdin | $24 | $20.09 | -22.2% | Jul 3, 2024 |
| UBS | Erika Najarian | $22 | $20.51 | -28.7% | Apr 4, 2024 |
| Piper Sandler | Scott Siefers | $15 | $14.1 | -51.4% | Oct 25, 2023 |
| Barclays | Analyst unavailable | $29 | $21.92 | -6.0% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $25 | $20.71 | -19.0% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $28 | $20.4 | -9.2% | Dec 16, 2022 |
| Jefferies | Ken Usdin | $22 | $18.92 | -28.7% | Jul 11, 2022 |
| UBS | Erika Najarian | $32 | $24.59 | +3.7% | Jan 12, 2022 |
| Evercore ISI | John Pancari | $27 | $23.88 | -12.5% | Nov 16, 2021 |
| Odeon Capital Group LLC | Richard Bove | $27.7 | $23.8 | -10.2% | Nov 10, 2021 |
| Piper Sandler | Stephen Scouten | $28 | $23.85 | -9.2% | Oct 25, 2021 |
| Wells Fargo | Mike Mayo | $24 | $21.49 | -22.2% | Oct 4, 2021 |
| KBW | David Konrad | $18 | $19.12 | -41.7% | Jul 6, 2021 |
| Compass Point | Dave Rochester | $25 | $22.19 | -19.0% | May 18, 2021 |
Track every rating change on RF the moment it posts. Free to start.
Start free